Multimorbidity impacts cardiovascular disease risk following percutaneous coronary intervention: latent class analysis of the Melbourne Interventional Group (MIG) registry.
Journal Information
Full Title: BMC Cardiovasc Disord
Abbreviation: BMC Cardiovasc Disord
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Vascular Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThe study was approved by the Curtin University human research ethics committee (HRE2016-0372). Informed consent was waived by the Monash University human research ethics committee. Consent for publicationNot applicable. Competing interestsNo conflict of interest Competing interests No conflict of interest"
"Funding The Melbourne Interventional Group acknowledges funding from Abbott Vascular, Astra-Zeneca, BMS and Pfizer. These companies do not have access to data and do not have the right to review manuscripts or abstracts before publication. DS research supported by NHF and NHMRC grants. Professor Reid’s work is supported by NHMRC grants (GTN: 1136372)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025